Patent · US Active

Crystalline forms of (3-amino-oxetan-3-ylmethyl)-[2-(5,5-dioxo-5,6,7,9-tetrahydro-5lambda*6*-thia-8-aza-benzocyclohepten-8-yl)-6-methyl-quinazolin-4-yl]-amine

US10071999B2 · kind B2 · utility

1Cited by
0References
23Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 12, 2018
Grant dateSep 11, 2018
Priority date—
Expiry dateJan 12, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07B2200/13
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present invention relates to novel crystalline forms of compound (I),

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.